Retrospective Evaluation of Liposarcoma | Clinical Trial

Key information

Conditions

Survival , Tumor Neoplasms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinikum rechts der Isar

Munich, Bavaria, 81675, Germany

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with Liposarcoma treated surgically at our clinic

Exclusion criteria

N/A

Treatment and study plan

Patients with Liposarcoma

Procedure

Evaluation of Liposarcoma treated in a single center

Primary outcomes

Survival rate

Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Technical University of Munich

Other

Registry information

Acronym: RELiSa

Important dates

Study start: 2016
Primary completion: 2017
Study completion: 2017
First posted: Jan 27, 2017
Registry last updated: Jan 27, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting